Hertraz 440 (Trastuzumab) 440mg

Hertraz 440 contains trastuzumab 440mg, a monoclonal antibody used in targeted cancer therapy. Store between 2-8°C to maintain potency. Suitable for patients requiring HER2 receptor inhibition. Always follow healthcare provider guidance for use.

Strength

440mg

Pack Size

Storage

2-8ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Hertraz 440 (trastuzumab 440mg) is primarily used to treat HER2-positive breast cancer and metastatic gastric cancer. It works by targeting cancer cells that overexpress the HER2 protein, helping to slow or stop their growth. This medication is often prescribed alongside chemotherapy for improved outcomes. Patients may also encounter it under the brand name Herceptin for similar indications.

Side Effects

Hertraz 440 may cause mild to moderate effects such as fatigue, headache, or nausea. Some patients report chills or fever shortly after administration, which are usually temporary. Skin reactions at the infusion site are also reported but tend to resolve quickly. These effects vary by individual and should be monitored by a healthcare professional.

Precautions & Warnings

Store Hertraz 440 between 2-8°C and protect from light to maintain stability. Avoid freezing or shaking the vial. Always handle with care to prevent contamination. Patients should inform their healthcare provider of any allergies or ongoing treatments before use. Follow local guidelines for safe disposal of used vials.

Avoid Interactions

Hertraz 440 may interact with other medications that affect the immune system, such as immunosuppressants or live vaccines. Combining it with certain chemotherapy drugs could increase the risk of side effects. Patients should disclose all current medications to their doctor to avoid potential interactions. Alcohol consumption may exacerbate side effects like nausea or dizziness.

Frequently Asked Questions

Hertraz 440 is used to treat HER2-positive breast cancer and metastatic gastric cancer by targeting cancer cells that overexpress the HER2 protein.

Store Hertraz 440 between 2-8°C and protect from light; avoid freezing or shaking the vial.

Common effects include fatigue, headache, nausea, chills, or fever shortly after administration. Reactions vary by individual.

Yes, Hertraz 440 is a prescription medication and should only be used under healthcare provider supervision.

It may interact with immunosuppressants, live vaccines, or certain chemotherapy drugs. Always disclose all medications to your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.